Expression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patients

We recently reported the SART3 tumour-rejection antigen as possessing tumour epitopes capable of inducing HLA-class I-restricted cytotoxic T lymphocytes (CTLs). This study investigated expression of the SART3 antigen in breast cancer to explore an appropriate molecule for use in specific immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Suefuji, Y, Sasatomi, T, Shichijo, S, Nakagawa, S, Deguchi, H, Koga, T, Kameyama, T, Itoh, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363830/
https://www.ncbi.nlm.nih.gov/pubmed/11286471
http://dx.doi.org/10.1054/bjoc.2000.1690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363830/
https://www.ncbi.nlm.nih.gov/pubmed/11286471
http://dx.doi.org/10.1054/bjoc.2000.1690

Ejemplares similares